Mumbai, Aug. 17 -- The stock debuted at Rs 980, marking a premium of 21.44% to the issue price.

So far, the stock has hit a high of Rs 1,002.05 and a low of Rs 925.80. On the BSE, over 6.53 lakh shares of the company were traded in the counter so far.

The initial public offer of Molbio Diagnostics was subscribed 70.26 times. The issue opened for bidding on 10 August 2026 and it closed on 12 August 2026. The price band of the IPO is fixed between Rs 768 and 807 per share.

The qualified institutional buyers' (QIB) portion was subscribed 186.39 times, while the non-institutional investors' (NII) category was subscribed 49.80 times. The retail individual investors' (RII) segment was subscribed 12.96 times.

The IPO comprised a fresh issue ...